Unknown

Dataset Information

Novel germline CDK4 mutations in patients with head and neck cancer.


ABSTRACT:

Background

Cyclin-dependent kinase 4 (CDK4) together with its regulatory subunit cyclin D1, governs cell cycle progression through G1 phase. Cyclin-dependent kinase inhibitors, including p16INK4A in turn regulate CDK4. In particular, deregulation of the p16/CDK4/cyclin D1 complex has been established in a variety of human tumors including gliomas, sarcomas, melanoma, breast and colorectal cancer. However, changes in CDK4 have rarely been observed.

Method

In this study we used a combination of PCR-SSCP and direct sequencing for mutational screening of CDK4. DNA was isolated from peripheral blood leukocyte of patients with squamous cell carcinoma of head and neck, for screening germline mutations in coding regions of CDK4.

Results

Variations observed in exon 2 and 5 wer

SUBMITTER: Sabir M 

PROVIDER: S-EPMC3488972 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature